553 related articles for article (PubMed ID: 16516128)
1. New agents for the treatment of acute myeloid leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
3. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic agents in acute myeloid leukemia.
Stone RM
Exp Hematol; 2007 Apr; 35(4 Suppl 1):163-6. PubMed ID: 17379102
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia.
Ferrara F; Palmieri S; Mele G
Haematologica; 2004 Aug; 89(8):998-1008. PubMed ID: 15339685
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in the treatment of acute leukemia].
Kimura Y
Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
[TBL] [Abstract][Full Text] [Related]
7. Emerging treatments in acute myeloid leukaemia.
Kell J
Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
[TBL] [Abstract][Full Text] [Related]
8. Advances in understanding the biology and genetics of acute myelocytic leukemia.
McKenzie SB
Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784
[TBL] [Abstract][Full Text] [Related]
9. Towards a pathogenesis-oriented therapy of acute myeloid leukemia.
Hiddemann W; Spiekermann K; Buske C; Feuring-Buske M; Braess J; Haferlach T; Schoch C; Kern W; Schnittger S; Berdel W; Wörmann B; Heinecke A; Sauerland C; Büchner T;
Crit Rev Oncol Hematol; 2005 Nov; 56(2):235-45. PubMed ID: 16207531
[TBL] [Abstract][Full Text] [Related]
10. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.
Kuendgen A; Germing U
Cancer Treat Rev; 2009 Apr; 35(2):97-120. PubMed ID: 18951721
[TBL] [Abstract][Full Text] [Related]
11. Clinically useful prognostic factors in acute myeloid leukemia.
Ferrara F; Palmieri S; Leoni F
Crit Rev Oncol Hematol; 2008 Jun; 66(3):181-93. PubMed ID: 17996460
[TBL] [Abstract][Full Text] [Related]
12. [Acute myeloid leukemia].
Ohtake S
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2175-9. PubMed ID: 18079616
[TBL] [Abstract][Full Text] [Related]
13. New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities.
Bruserud O; Gjertsen BT
Stem Cells; 2000; 18(3):157-65. PubMed ID: 10840068
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
15. Acute myelogenous leukemia.
Shipley JL; Butera JN
Exp Hematol; 2009 Jun; 37(6):649-58. PubMed ID: 19463767
[TBL] [Abstract][Full Text] [Related]
16. Current therapeutic strategies for acute myeloid leukaemia.
Kolitz JE
Br J Haematol; 2006 Sep; 134(6):555-72. PubMed ID: 16848792
[TBL] [Abstract][Full Text] [Related]
17. Novel strategies for relapsed and refractory acute myeloid leukemia.
Mato AR; Morgans A; Luger SM
Curr Opin Hematol; 2008 Mar; 15(2):108-14. PubMed ID: 18300756
[TBL] [Abstract][Full Text] [Related]
18. Treatment concepts of acute promyelocytic leukemia.
Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
[TBL] [Abstract][Full Text] [Related]
19. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
